Investorideas.com newswire, news and commentary for leading sectors

Wednesday, February 26, 2014

Breaking News: Award winning producer Chad A. Verdi to produce three feature films over the next 10 months beginning with Bad Hurt and ending with Bleed For This

EAST GREENWICH, RI - February 26, 2014 (Investorideas.com Newswire) Verdi Productions and The Woodhaven Production Company are pleased to announce that award winning producer Chad A. Verdi will produce three feature films over the next 10 months. Verdi is now teamed with Oscar-winner Martin Scorsese (THE DEPARTED, GOODFELLAS) and Oscar nominee Emma Tillinger Koskoff (THE DEPARTED, THE WOLF OF WALL STREET) on two of his next three films.

The first film that Verdi and his wife Michelle will executive produce is titled Bad Hurt. Bad Hurt is currently being filmed in NY with principal photography ending in mid- March. Bad hurt, a drama which follows the struggles of a blue collar American family, is directed by Mark Kemble off his screenplay which he wrote alongside Jamieson Stern. The film stars, Theo Rossi ("Sons of Anarchy", "Cloverfield", "Red Sands") Karen Allen("Indiana Jones, Raiders of the Lost Ark", "The Perfect Storm","Scrooged") and Ashley Williams ("Margin Call", "Something Borrowed", "How I Met Your Mother").
The second feature is titled Almost Mercy and was written by B. Dolan and Tom DeNucci. Verdi tapped DeNucci to direct and produce. Sam Eilertsen will be the director of photography. The film tells the tale of a quaint little town with a dark secret. We focus on two outcasts, Jackson and Emil, victims of the town’s seedy underbelly. Ticking time bombs, they are seeking revenge. It's a race to see who will unravel first. Dealing with issues that are far too common in our society, the film focuses on a new breed of terror. A fear that is now closer to home than ever imagined.
The film stars Kane Hodder ("Jason X", "Monster", "Hatchet"), best known for his portrayal of Jason Voorhees in the "Friday the 13th" franchise, who will play Coach Elwood, a seedy, overly aggressive gym teacher, driven by self-help books and his obsession with inflicting mental pain on his students. The great Bill Moseley ("The Devil's Rejects", "Night of the Living Dead", "Army of Darkness") will play Pastor Johnson, an overzealous preacher, who's got the whole town fooled.
Verdi stated, "Tom DeNucci has directed two great films for us and we expect that he will repeat this again." Verdi added, “DeNucci was elevated to producer on this feature film because of all his hard work and dedication to the project. I am very happy that the flowing producers and ex-producers will be joining Tommy and I in association with LDI unlimited, David Gere, David Lussier as producers and, Sherry Lussier, Michael Cole, Taylor Van Zant, Seth Rosenblit with Michelle Verdi as ex-producer and music supervisor.
The third film is titled BLEED FOR THIS and tells the true-life story of 5-time world champion Rhode Island boxer Vinny Pazienza; as he recovers from a near fatal car accident that left him with a broken neck. He then goes on to win three additional world boxing titles, one of the most incredible and dramatic comebacks in sports history.
Golden Globe nominated actor Aaron Eckhart, (THE DARK KNIGHT, OLYMPUS HAS FALLEN, I, FRANKENSTEIN) will take on the role of Paz's boxing trainer, Kevin Rooney. Rooney was the trainer to Mike Tyson when Tyson won his first heavyweight championship. Rooney had a major role in changing Vinny's boxing style that lead him to become one of only two boxers ever to win titles in the lightweight and junior middle weight class in 1991. The other boxer was Roberto Duran who Vinny fought twice with victories for Vinny in both fights.
Miles Teller (THE FANTASTIC FOUR, 21 & OVER, PROJECT X), currently starring in THAT AWKWARD MOMENT, in theaters now, will take on the role of Vinny Paz.
The powerhouse team is led by writer/director Ben Younger (BOILER ROOM, PRIME), Oscar-winner Martin Scorsese (THE DEPARTED, GOODFELLAS), Oscar-winning producer Bruce Cohen (AMERICAN BEAUTY, SILVER LININGS PLAYBOOK), Emma Tillinger Koskoff (THE DEPARTED, THE WOLF OF WALL STREET), Noah Kraft (LOOSIES), award-winning RI producer Chad A. Verdi (LOOSIES, A BET'S A BET, BAD HURT), Michelle Verdi (LOOSIES, A BET'S A BET, BAD HURT ).
Verdi stated, "I am very excited about taking on the challenges of producing these three films over the next 10 months. It's a very special time for my wife Michelle and I, and our whole production team. It's not often a production company like ours has the luxury of turning down fully funded projects. We are currently booked through 2016 and it's a great position to be in."
Verdi's home-grown East Greenwich Company, Verdi Productions/Woodhaven Production Company, has produced six feature films in Rhode Island over the past four years. BLEED FOR THIS is his most ambitious project to date, with an estimated budget between $10,000,000 and $20,000,000.
Verdi added, "My producing partners Noah Kraft, my wife Michelle, and I got involved in the film business in 2009 with one purpose: to have the story of Vinny Paz told. The best thing that ever happened to this project was Ben Younger coming on board to write and direct BLEED FOR THIS. BLEED FOR THIS is Ben's vision and with the support of Martin Scorsese, Bruce Cohen and Emma Tillinger Koskoff, this film is destined for greatness. I was introduced to Martin and Emma through Senator Sheldon Whitehouse, who has been instrumental in helping me develop these projects." Verdi added, "Writer/director Tom DeNucci will be brought on board as a consultant to the project. Tom will be working directly for me over the next several months in order for us to be ready to shoot sometime this summer."
CONTACT INFORMATION
For more information, please contact
Chad A. Verdi
http://www.imdb.com/name/nm3838148/?ref_=fn_al_nm_1
Mary Larsen
Executive Coordinator
401.447.7403
Verdi Productions & The Woodhaven Production Company
253 Main Street East Greenwich, RI 02818
Verdifilms.com, Woodhavenfilms.com

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Announces Agreement with DaVita Clinical Research

SAN DIEGO - February 26, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that that it has reached an agreement in principle with DaVita Clinical Research® (DCR) to provide clinical management services that will support forthcoming studies of the Aethlon Hemopurifier®. The Hemopurifier® is a first-in-class therapeutic device that targets the rapid elimination of circulating viruses and tumor-secreted exosomes that suppress the immune system of cancer patients.

DCR is a specialty contract research organization (CRO) with experience in conducting more than 300 early phase clinical trials. As a subsidiary of DaVita Healthcare Partners, DCR has access to one third of the total US end-stage renal disease (ESRD) patient population and maintains a network that exceeds 150 investigative physicians practices at more than 250 clinical sites.
Aethlon previously disclosed that the United States Food and Drug Administration (FDA) had approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. Under the feasibility study protocol, Aethlon is to enroll ten ESRD patients infected with Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. Successful completion of the feasibility study will set the stage for Aethlon to conduct pivotal studies required for market clearance to treat HCV and potentially other disease indications.
"Not long after the FDA had cleared our IDE, we were presented an opportunity to advance a clinical relationship with DaVita Clinical Research,” stated Aethlon Chairman and CEO, Jim Joyce. "As a result, we have transitioned our clinical plan from working with a single-site institute to working with a single institute that has a multitude of clinical sites across the United States. Beyond maintaining the resources necessary to advance our feasibility study, DaVita's proven extracorporeal expertise, patient accrual capabilities and expansive clinical infrastructure provide a foundation to support our long-term vision of treating a variety of infectious disease and cancer indications."
Aethlon further disclosed that the DCR agreement was entered into on a non-exclusive basis and is pending the completion of a definitive agreement, which will include a work order describing the full scope of services to be provided by DCR to Aethlon Medical.
DaVita Clinical Research is a wholly owned subsidiary of DaVita HealthCare Partners (NYSE:DVA), a Fortune 500 company and parent company of DaVita and HealthCare Partners. DaVita is a leading provider of kidney care in the United States and abroad, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of December 31, 2013, DaVita operated or provided administrative services at 2,074 outpatient dialysis centers in the United States serving approximately 168,000 patients, and at 73 centers in ten countries outside of the United States. HealthCare Partners(R) manages and operates medical groups and affiliated physician networks in California, Nevada, Florida, Arizona and New Mexico in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2013, HealthCare Partners provided integrated care management for approximately 765,000 managed care patients. For more information, please visit DaVitaHealthCarePartners.com.
About Aethlon Medical, Inc.
Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients. The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumorsecreted exosomes that suppress the immune system of cancer patients. Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression. Additional information can be found at www.AethlonMedical.com
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the ESI will not be able to commercialize its future products, that the FDA will not approve the initiation of the Company's existing or future clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: three thousand per month effective June 2013
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

Biotech/Pharma Companies Targeting Pancreatic Cancer: (SBFM), (NLNK), (LLY, NYSE), (CELG)

Point Roberts, WA, New York, NY - February 26, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Companies include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE: LLY) and Celgene (NASDAQ::CELG).

According to the Pancreatic Cancer Action Network "Pancreatic cancer is currently the fourth leading cause of cancer death in the United States, and is anticipated to become the second by 2020.”
In their fact sheet they also note " Pancreatic cancer is one of the nation's deadliest cancers with a five-year relative survival rate of just 6 percent. An estimated 73 percent of patients will die in the first year of diagnosis. In 2014, an estimated 46,420 people will be diagnosed with pancreatic cancer in the United States, and approximately 39,590 will die from the disease.”
Decision Resources (http://www.decisionresources.com/),one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the pancreatic cancer therapy market will nearly double to $1.3 billion in 2022, owing to the launch and rapid uptake of three high-priced agents—Celgene (NASDAQ::CELG)/Taiho's Abraxane, Onconova Therapeutics/Baxter International/SymBio Pharmaceuticals' Estybon and Merrimack Pharmaceuticals' MM-398 (a novel formulation of irinotecan). Even though these agents do not substantially improve the overall survival of pancreatic cancer patients, they will have a significant impact on current treatment.
The Pharmacor Pancreatic Cancer report also finds that significant commercial reward awaits developers of therapies that are more effective and better tolerated than the FOLFIRINOX regimen in this disease, as the need for efficacious, well-tolerated therapies will remain through 2022.
NewLink Genetics (NASDAQ: NLNK) has been of the top gainers for 2014,gaining over 90%.NewLink's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications.
Investorideas.com Newswire Their product, RAlgenpantucel-L is an investigational HyperAcute™ immunotherapy for pancreatic cancer. The product consists of 2 pancreatic cancer cell lines (HAPa-1 and HAPa-2) that have been genetically modified to express alpha-gal carbohydrates on cell surface molecules.1 Upon injection into the patient, the alpha-gal stimulates an immune response against pancreatic cancer-specific antigens in the tumor cell lines. The patient's immune system then targets its own pancreatic cancer cells, destroying them.1 In the adjuvant setting, the immune response targets and eradicates residual tumor cells in conjunction with chemotherapy and chemoradiation.1,2
Algenpantucel-L is currently being studied in combination with standard of care in two phase 3 trials:
Last fall the company reported greater than expected responses to follow-on chemotherapy after treatment with algenpantucel-L or tergenpumatucel-L HyperAcute immunotherapy. Three pancreatic cancer patients were followed for response to subsequent salvage chemotherapy treatment after progressing on algenpantucel-L therapy. All three patients experienced durable (12-36 months), complete responses.
Sunshine Biopharma Inc. ( OTCBB: SBFM ), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, recently announced that it is targeting pancreatic cancer as second indication for its leading compound, Adva-27a.
Investorideas.com Newswire As previously announced, Adva-27a was found to be effective at killing Pancreatic Cancer Cells in vitro. Based on initial data, the company is now advancing research using Adva-27a for pancreatic cancer treatment.
The initial study, as reported in June 2013, was carried out in the very aggressive Pancreatic Cancer cell line, Panc-1. Adva-27a was able to kill these cells with an IC50 of less than 4 micromolar, a pharmacologically very favorable drug concentration.
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under US patent number 8,236,935.
The Company also announced that it has initiated the construction of mouse xenograft models for pancreatic cancer as part of the plans of positioning Adva-27a for clinical development for pancreatic cancer in parallel with multidrug resistant breast cancer. The work is being conducted in collaboration with Sunshine Biopharma's parent company, Advanomics Corporation, the co-recipient of $1.45 million in research grants in Canada. As previously announced (see press release dated June 4, 2013), Adva-27a, a Topoisomerase II inhibitor, was found to be effective at destroying cells of the very aggressive pancreatic cancer cell line, Panc-1.
"Conducting tests in pancreatic cancer xenograft models is the next step in our preparations for doing parallel breast cancer and pancreatic cancer clinical trials of Adva-27a," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "Pancreatic cancer is an extremely aggressive form of cancer with essentially no effective treatment options available today. We are heartened by the prospects that Adva-27a could become an effective therapy for patients suffering this deadly form of cancer."
According to Global Industry Analysts, Inc. in their recent report, "Eli Lilly's (LLY:NYSE) Gemzar (Gemcitabine) is the current gold standard of care for locally advanced and metastatic disease, with a dominance that is undisputed despite a median survival of less than 6 months and rate of one-year survival of around 18%, as stated by the new market research report on Pancreatic cancer drugs. Though the odds of survival are somewhat better in other forms of cancer, the rate of five-year survival for the most common form of pancreatic cancer, Adenocarcinoma of the pancreas is less than 5%, with majority of patients surviving just a few months. "
www.Investorideas.com - Big ideas for Global Investors
Investorideas.com is a global news source and resource base for investors following tech stocks, biometric stocks, water stocks, biotech stocks, energy stocks, mining stocks, renewable energy stocks, nanotech and Latin American stocks.
Follow Investorideas.com on Twitter  
Follow Investorideas.com on Facebook  
Follow Investorideas.com News on Linkedin.com/today
Sign up for free news alerts and get free research tools:
http://www.investorideas.com/Resources/Newsletter.asp
Join us and become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in leading sectors
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investor ideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure investor ideas has been compensated with 144 shares for news and content publication ( 100,000 per three month period)
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

NXT-ID's (OTCQB:NXTD) Wocket™; a Next Generation Smart Wallet and COIN Coming to Consumers in 2014 to Replace all the Credit Cards in Your Wallet

Point Roberts, WA, NEW YORK, NY - February 26, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including biometrics and mobile technology, issues an exclusive follow-up interview with Mr. Gino Pereira, Chief Executive Officer of NXT-ID, Inc., creator of Wocket™; a next generation smart wallet and Mr. Kanishk Parashar, CEO of Coin, as each company prepares to launch their products to consumers this year. Both products take aim at consumer’s bulky wallets and hope to replace all credit cards in a wallet with one simple solution.

Alan Goode, Managing Director of GoodeIntelligence.com notes, “With the recent attacks that saw millions of customers of Target having their personal information, including payment card details, stolen, there is a pressing need to improve the security of payment services at the physical store. EMV is one solution that could improve the security posture of card present transactions at the physical point of sale but perhaps, what we need is a leap to next generation technology that combines convenience and security. Mobile payments are one option but the complexity of the ecosystem has created problems for combining all of our card details within a secure mobile wallet that is accepted at all retail outlets. There are alternatives; innovative technologies that could solve the problem of convenience and security such as NXT-ID’s Wocket and Coin. They take the approach of combining the ubiquity of card-based payments with a single, secure digital wallet that can hold all of a consumer’s card details in the single device."
Another new start-up competitor has emerged on the landscape, called the Loop Wallet™ App, that says it scans, stores and organizes all your cards on a smartphone securely, and lets you pay at virtually every retailer today.
It is clear that this is the year for the race to bring consumers the most innovative payment solutions; consumers and investors stay tuned!
NXT-ID, Inc. Interview:
Q: Investorideas.com
Gino you recently released a product FAQ, 'Get to knowWocket™’ that shared a lot of new product features including the number of cards it can hold (up to 10,000). Can you share some of the new product features?
A: Gino Pereira, Chief Executive Officer of NXT-ID, Inc
Certainly. These product features are not so much new but we are releasing more details as we get closer to product launch. There’s still more to come! I would encourage those who are interested to visit our website www.nxt-id.com and read the FAQ’s on the Wocket product page.
Essentially, Wocket is a next generation smart wallet that locks all of your private information in an electronic vault where only an authorized user can gain access to the information and has a single dynamic card for all your payments You can store up to 10,000 records in Wocket including credit, debit, loyalty, gift, ID and membership cards as well as coupons and even medical records, to name a few. The Wocket completely replaces your wallet. It even allows for you to carry cash!
Q: Investorideas.com
Your company recently published filings regarding a private placement funding that was non- dilutive and described by analysts as investor friendly. Can you share what that means in laymen’s terms?
A: Gino Pereira, Chief Executive Officer of NXT-ID, Inc
As a public company we wanted to show our investors that, as a management team, we believed in the company, so the founders returned stock to the Company on a one for one basis with the new shares that were issued in the financing. As a result, existing investors are not diluted by having more shares issued and the Company has more money in the bank!
Q: Investorideas.com
Can you discuss the security features on Wocket and what differentiates it from the competition?
A: Gino Pereira, Chief Executive Officer of NXT-ID, Inc.
Wocket uses multifactor biometric and PIN identification to allow access to private information. In addition, this information is stored on a secure encrypted chip inside the Wocket. This information is input directly into Wocket and does not come from the internet or the cloud or a phone or other computer. The information on the dynamic card is zeroised after one swipe, so if the card itself is lost, it carries no information about the owner.
Q: Investorideas.com
When is your expected roll- out to debut the Wocket and are you on schedule?
A: Gino Pereira, Chief Executive Officer of NXT-ID, Inc.
We expect to debut Wocket at the end of March or early April and we are currently on schedule for that time frame.
Q: Investorideas.com
How do you view the competitive landscape and how confident are you in Wocket’s technology?
A: Gino Pereira, Chief Executive Officer of NXT-ID, Inc.
I think that the whole payments space is going through tremendous disruption at the moment with a number of players, both large and small, looking for ways to improve security and functionality.
There will potentially be several winners who achieve this in slightly different ways. We think of ourselves as not just a company enabling a more convenient method of payment but we are a next generation authentication company with solutions to multiple problems across different platforms. Wocket is an authentication device as well as your wallet, and in combination with our one time use dynamic pairing algorithms, can authenticate the user for payments both at the point of sale (POS) for card present transactions as well as for card not present transactions such as online purchases. Wocket can also authenticate you for seamless access to smart devices of the future with access to your house and your car! We have technologies for tomorrow’s world that are not only a lot more secure than what is available today but also will be convenient and easy to use.
COIN Interview:
Q: Investorideas.com
I read that less than a week after your first media launch, you reached your initial pre-sale goal. What is the ongoing interest like for presales - has the momentum continued?
A: Kanishk Parashar, CEO of Coin
We are very excited about our continued growth after hitting our $50,000 goal in just 40 minutes after launch, but we aren't releasing any more specifics at this time. We want to keep our focus on manufacturing the product as we ramp up to start shipping this summer.
Q: Investorideas.com
The company also addressed some of the security concerns following the initial media release. Can you tell us what changes were made with regard to security?
A: Kanishk Parashar, CEO of Coin
In total below are the security features of Coin:
  • The Coin app is password protected and is 128-bit/256-bit encrypted for all storage and communication with its easy-to-use consumer app to ensure the safety of your identity.
  • With Coin, you can only add your cards that match your personal information stored in the app. Your full name will be printed on the Coin and your signature will be on the back.
  • Coin sends you a push notification alerting you if you leave your Coin behind and locks automatically if you go too far away, making it unusable if anyone tries to pay with it. If you need to unlock your Coin without your phone - you can enter in your single button passcode (similar to Morse code) so you always have your Coin available for use.
  • On the digital screen, you will see the nickname that you assigned to your card, the last 4-digits of the card and the expiration date. If you need any other information off your card - you can go to your Coin app which has front and back images of your card.
  • Coin has an alarm, that remembers how many times your Coin is being swiped, and will alert you via the app if it is being swiped fraudulently when out of your hands.
  • Coin can lock for one particular card so it can’t be changed to a different card by a merchant or waiter for example.
Q: Investorideas.com
I read in late January in VC Post that the company is raising approximately $15 million in a Series-A financing. Can you give us an update on that, and are you able to disclose any key investors in the raise? (http://www.vcpost.com/articles/21195/20140129/us-credit-card-wallet-coin-raising-15m-in-series-a-funding-sources.htm)
A: Kanishk Parashar, CEO of Coin
No comment.
Q: Investorideas.com
Is the company still on track to release the product to consumers for this summer?
A: Kanishk Parashar, CEO of Coin
Yes - Summer 2014.
Q: Investorideas.com
In closing, can you sum up the consumer response and attitude towards your product?
A: Kanishk Parashar, CEO of Coin
We are very excited by the initial consumer response that we have received so far. Our backers have been very positive and patiently awaiting the release of Coin this summer.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
Corporate:mailto:info@nxtid.com
About COIN
Hold all your cards in one Coin.
https://onlycoin.com/about/
Goode Intelligence is an independent research and consultancy company that provides quality advice to global decision makers in business and technology. Goode Intelligence works in information security, mobile security, authentication and identity verification, biometrics, enterprise mobility and mobile commerce sectors. Founded in 2007 by Alan Goode and headquartered in London Goode Intelligence helps both technology providers, investors and IT purchasers make strategic business decisions based on quality research, insight and consulting.
Goode Intelligence works with a cross-section of clients, from global brands that are ranked on the FTSE/Fortune 100 to start-up technology companies.http://www.goodeintelligence.com
Previous Wocket™ and COIN Interview with Investorideas.com
December 9 th 2013: http://www.investorideas.com/CO/NXT/news/2013/12091ep.asp
About www.InvestorIdeas.com : Big Ideas for global investors
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Sign up for free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas is currently compensated by NXTD: five thousand per month and Investorideas is long shares in the company from previous contracts. More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Contact Information
Investorideas.com
800-665-0411
Sources: Investorideas.com, COIN, NXT- ID Inc., Goode Intelligence

Tuesday, February 25, 2014

Investorideas.com Security and Defense Conference; Present your company with top thought leaders in cybersecurity, biometrics, biodefense and other security issues

February 25, 2014 (www.investorideas.com newswire) Present live in New York and online globally to investors, media and industry peers. Be in the company of some of the best and most respected thought leaders in the industry!

Investorideas.com Security and Defense Conference; Game Changing Technologies: The Face and Future of Security Key Themes: Biometrics, Biodefense and Cybersecurity
When /where :
Tuesday, March 11, 2014, The New York Hilton Midtown, New York City and Online in Scribblelive platform ( we will send online info before conference goes live)
Conference info: http://www.investorideas.com/Conference/
Speaker list: includes cybersecurity expert Roger Cressey and Janice Kephart Founder and CEO of The Secure Identity and Biometrics Association (SIBA) http://www.investorideas.com/Conference/Speakers.asp
Presenting Companies: includes American Public University System (NASDAQ:APEI) - Dr. Clay Wilson is the Program Director for Cybersecurity http://www.investorideas.com/Conference/Companies.asp
Presenting Company Opportunities:
  • 15 minute presentation in the main conference room at the live event in New York
  • Your presentation will be streamed live to investors, industry peers and media all over the world who are not attending the live event
  • Your session will be recorded and available to you for your own use after the event
  • Logo placement on all conference marketing materials
  • Press releases announcing your participation
  • Ability to distribute marketing materials at the event
  • Added bonus: Investorideas.com will publish all your company press releases on the Investorideas.com newswire up to the event date!
Register to attend free: http://www.investorideas.com/Conference/Conference-Registration.asp
8:00 – 9:00AM Registration & Networking
5:45 – 7:15PM Cocktail Reception
Media Partners:
Media partners include www.SecuritySolutionsWatch.com , a breaking news site covering new security solutions and business trends; SecurityStockWatch.com for investors following the sector; www.Wallstreetcalendar.com , informing the institutional investment community; Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ); Global Security Finance ( www.globalsecurityfinance.com ), an online daily news and data service covering the physical, cyber and identity security and defense sectors; Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors; www.biometgricupdate.com and http://www.biometricstechnologywatch.com/.
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners:
D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Receives US$10 Million Commitment from Sandstorm Gold for Underground Mine Option at Santa Elena

Vancouver, British Columbia - February 25, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to announce it has received notice of exercise of the Underground Mine Option from Sandstorm Gold Ltd. (“Sandstorm”) for the Santa Elena Mine, Sonora, Mexico. This Option allows Sandstorm to purchase 20% of the gold produced from underground operations at the Santa Elena. In consideration of exercise of the option, Sandstorm will make an additional upfront deposit of US$10 million to the Company on or before March 17, 2014 and will continue to make ongoing per ounce payments of US$350 until 50,000 ounces of gold have been delivered to Sandstorm, inclusive of 18,593 ounces already received from open-pit production, at which time the payments will increase to US$450 per ounce of gold.

N. Eric Fier, President and COO commented; "The upfront deposit of US$10 million will improve our cash balance and further enhance the Company’s financial position to achieve its 2014 goals for the mine expansion at Santa Elena. We are pleased with Sandstorm’s expression of confidence in Santa Elena Mine, and our continued mutually beneficial relationship."
About SilverCrest (TSX: SVL; NYSE MKT: SVLC)
SilverCrest Mines Inc. (TSX: SVL; NYSE MKT: SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
N. Eric Fier, President and COO
SILVERCREST MINES INC.
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108 or Toll Free: 1-866-691-1730
(604) 694-1761
info@silvercrestmines.com
www.silvercrestmines.com
Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Monday, February 24, 2014

Mining Stock Alert: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Graduates to Toronto Stock Exchange Trading Commences February 24, 2014

Vancouver, British Columbia - February 24, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) is pleased to announce that the Company will begin trading on the Toronto Stock Exchange ("TSX") on February 24, 2014 following its graduation from the TSX Venture Exchange (the "TSXV"). The common shares of the Company will be concurrently delisted from TSXV upon commencement of trading on TSX. The trading symbol for the common shares of SilverCrest will remain "SVL". The common shares of the Company are also listed on NYSE MKT under the symbol "SVLC.

N. Eric Fier, President and COO stated; "We are certainly pleased with this recognition of the growing stature of SilverCrest. The acceptance for trading of our common shares on the TSX is another significant milestone in the development of our corporate growth. We expect the higher profile afforded by the TSX will give the Company exposure to new segments of the investment community and provide greater liquidity for those investors wishing to trade the shares of our Company".
About SilverCrest (TSX VENTURE:SVL)(NYSE MKT:SVLC)(NYSE Amex:SVLC)
SilverCrest Mines Inc. (TSX VENTURE:SVL)(NYSE MKT:SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
N. Eric Fier, President and COO
SILVERCREST MINES INC.
Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108 or Toll Free: 1-866-691-1730
(604) 694-1761
info@silvercrestmines.com
www.silvercrestmines.com
Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Thursday, February 20, 2014

Investorideas.com Security Conference Adds Viscount Systems (OTCQB:VSYS) to Presenters; Speakers Discuss Key Security issues including Biodefense, Biometrics and Cybersecurity

New York, NY - February 20, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, announces new speakers and presenters for its upcoming Security and Defense Conference, “Game Changing Technologies: The Face and Future of Security”, to be held live in New York and online on March 11, 2014.

New financial panelists include Manish Thakur, Managing Partner of Hudson Fairfax Group and Jason Kolbert, Head of Healthcare Research, Senior Managing Director and Biotechnology Analyst at Maxim Group.
Added to presenting companies is Viscount Systems (OTCQB:VSYS), a Canadian manufacturer of advanced physical access control systems that combines traditional access control performance with cyber security (true convergence of logical and physical access) to increase security while driving down facility costs to secure offices, hospitals, critical infrastructure, schools, banks, and manufacturing. The company’s unique offering satisfies new US Federal Government standards for increased protection of facilities from external threats. http://viscount.com/
The theme of the conference is 'game changing technologies, the face and the future of security’ and will be discussing developments in biodefense, biometrics including fingerprint, voice and facial recognition, cyber security and other leading edge technologies.
The agenda will include a financial panel, and industry panel and presenting companies showcasing their technologies.
Recently added media partners include BiometricUpdate.com, a leading news property that publishes breaking news, analysis, and research about the $7 billion global biometric market.
"We project that the global biometrics market will grow to $15 billion by 2015 from its 2012 estimated value of $7 billion," states Stephen Mayhew, President of Biometrics Research Group Inc., an independent market research consultancy, which publishes BiometricUpdate.com, the most trusted and authoritative source for news and industry intelligence in the sector.  "The market for automated fingerprint identification systems and fingerprint biometric technologies account for the greatest share of the global biometrics market and is forecast to continue to be the main source of overall market revenues from 2010 to 2015. We believe the fingerprint modality was valued at $5 billion in 2012 and is expected to reach nearly $10 billion in 2015. Face, iris, vein, and voice recognition biometric technologies together form the second largest segment. This sector was worth an estimated $2 billion in 2010 and is expected to reach $5 billion in 2015."
"Biometric technology is advancing faster than many people realize. The consumer and mobile spaces have seen huge gains in the past year, bringing authentication and payment systems to the forefront of this discussion. All the while, security and defense applications are more technologically advanced today than they ever have been and international adoption is soaring.”  -- Adam Vrankulj, Managing Editor, BiometricUpdate.com.
New speakers added:
Manish Thakur, Managing Partner of Hudson Fairfax Group
Manish Thakur is Managing Partner of Hudson Fairfax Group, a strategic investment firm based in New York, Washington and London, focused on cybersecurity, intelligence, big data analytics, and defense private equity. Manish has spent over 20 years covering defense, technology, telecommunications and satellite companies as a principal investor, CFO and investment banker. Before founding HFG, he worked at such firms as Merrill Lynch, SG Cowen and HSBC, where his responsibilities included private equity and strategic investments, initial public offerings, and mergers and acquisitions. Manish also serves as National Security Coordinator for a Capitol Hill-based political action committee. Manish holds an MBA in Finance from Columbia University Graduate School of Business, and a BSc (honors) in Economics from the University of London.
Jason Kolbert, Head of Healthcare Research, Senior Managing Director and Biotechnology Analyst, Maxim Group
Jason's career began as a chemist in the pharmaceutical industry, and evolved into a product, and marketing manager with Schering-Plough in Japan. Upon returning from Japan, Jason joined Salomon Smith Barney, as a research associate which has now evolved into an 18 year career on Wall Street as a ranked biotechnology analyst.
Mr. Kolbert today is a senior managing director with the Maxim group and the head of Healthcare Research as well as a covering analyst. As the head of Healthcare, Jason manages the Healthcare effort to maintain a balance of large capitalized relevant institutional coverage combined with the next generation of small capitalized emerging companies that will influence the sector. As a covering analyst Mr. Kolbert's focus is across several therapeutic areas with an emphasis in antiviral medicine, regenerative medicine, oncology and immunology (cell therapy). Mr. Kolbert is noted for being among the first analysts to focus on the changing landscape for Hepatitis C therapy, identifying Pharmasset in its early days as a company with paradigm shifting nucleoside technology (subsequently acquired by Gilead for $11 billion). Today Mr. Kolbert is making the same call for Stem Cell Therapy, identifying the sector as having the potential to alter current treatment paradigms.
Mr. Kolbert spent seven years at Citi Group as a traditional sell side analyst followed by seven years on the buy side as a portfolio manager with the Susquehanna International Group. Mr. Kolbert most recently returned to his analyst role after spending a year as the head of business development for a public cell therapy company. Today at Maxim with his colleagues Mr. Kolbert oversees a team responsible for covering 70 companies and supporting the needs of the firm.
The growing list of speakers and presenters includes Kris Tuttle, Director of Research for SoundView Technology Group; cybersecurity expert and counterterrorism analyst Roger Cressey*, Partner with Liberty Group Ventures; and Kiersten Todt**, President and Managing Partner of Liberty Group Ventures.
*From 2004 - 2013, Roger Cressey served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC.
**Ms. Todt has commented on homeland security and sport security issues in multiple media outlets, including MSNBC, NPR, Bloomberg, and The Wall Street Journal. Her work on sport security has been published in two editions of The International Centre for Sport Security Journal.
Other speakers include Marty Martin, CEO of Crane & Crane Consulting, who also has a background with the CIA, NSA, and the U.S. Army, Scott Greiper, President and Founding Partner of Secure Strategy Group, Scott Sacknoff, President of Spade Defense Index (NYSE: ^DXS), Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA) and Phil Agcaoili, Chairman, Ponemon Institute Fellows Co-founding Member, Cloud Security Alliance Board Member, Mobile Active Defense.
Presenting Companies currently include:
NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB:NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com /, http://www.wocketwallet.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Tekcapital, Ltd. - The World's Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. http://tekcapital.com/
PositiveID Corporation
PositiveID Corporation (OTCBB:PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. http://www.PositiveIDCorp.com
See more companies: http://www.investorideas.com/Conference/Companies.asp
Investorideas.com Security and Defense Conference:
Game Changing Technologies: The Face and Future of Security
Tuesday, March 11, 2014,The New York Hilton Midtown and Online at a unique content and syndication platform
Hear some of the top thought leaders in Biometrics, Biodefense and Cybersecurity discuss the "Face and Future of Security ". Hear Industry experts, financial experts and management of companies with leading edge technology in this one day session. Investors can gain insight into key trends for 2014 and beyond!
Investors, media and industry service providers: Register here free: http://www.investorideas.com/Conference/Conference-Registration.asp
Presenting Companies: Visit the conference page to learn more and sign up:
http://www.investorideas.com/Conference
Media Partners:
Media partners include www.SecuritySolutionsWatch.com , a breaking news site covering new security solutions and business trends; SecurityStockWatch.com for investors following the sector; www.Wallstreetcalendar.com , informing the institutional investment community; Australian Security Magazine ( http://www.australiansecuritymagazine.com.au/ ); Global Security Finance ( www.globalsecurityfinance.com ), an online daily news and data service covering the physical, cyber and identity security and defense sectors; Hedge Connection ( https://www.hedgeconnection.com ), an interactive, web-based marketing tool available to hedge funds and investors; www.biometgricupdate.com and http://www.biometricstechnologywatch.com/ .
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners:
D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Wednesday, February 19, 2014

Investorideas.com Security Conference Features Preview Q&A with Scott Sacknoff, President of Spade Defense Index (NYSE: DXS)

New York, NY - February 19, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense, issues a preview Q&A with Scott Sacknoff, President of Spade Defense Index (NYSE: ^DXS). Scott will be one of the financial panelists at the upcoming Security and Defense Conference, Game Changing Technologies: The Face and Future of Security", to be held live in New York and online on March 11, 2014.

Scott Sacknoff manages the SPADE Defense Index (NYSE: DXS) which serves as the underlying index for InvescoPowershares Aerospace & Defense ETF (NYSE ticker: PPA). http://www.spadeindex.com/
The theme of the conference will share insight into developments in biodefense, biometrics including fingerprint, voice and facial recognition, cyber security and other security and defense issues. The agenda will include a financial panel, and industry panel and presenting companies showcasing their technologies. The current list of speakers represents some of the top thought leaders in biometrics and cybersecurity including cybersecurity expert and counterterrorism analyst Roger Cressey.
Learn more about the conference:
http://www.investorideas.com/Conference
Interview
Investorideas.com: Let's start with a quick recap of 2013 and the start of the first quarter.
SMS: A good place to start. Although many though the year would be all gloom and doom for the sector with the Pentagon's budget on a downward slope from the peak in war spending and the expected impact from sequestration, I held a more moderate view. Although there would be stress in the system, I believed that the rise in sales to international defense customers combined with the upcycle in commercial aerospace spending would offset the U.S. government budget declines and things would not be as bad as some forecasted. But even I couldn't foresee how good a year it would become. By the end of 2013, the SPADE Defense Index has gained 48.18%, nearly 20% more than the gain in the S&P500.
Investorideas.com: And the start of 2014?
SMS: The sector is still at or near its historic high. Year to date, the market is down 0.4% but the aerospace and defense sector is up 3.4%.
Investorideas.com: Any patterns you've seen in the numbers?
SMS: We noticed in 2013 that investors interested in the sector appeared to choose individual companies over fund-related —whether Boeing, which was up 81% in 2013 or Lockheed Martin, which gained 61% while offering a 4% dividend. Toward the end of 2013 and continuing through the beginning of the year, we've noticed an inflow into funds such as PPA. This makes some sense after the sector's significant gains in 2013. The ETF gives exposure to the sector and diversification from positions in any one company. Although most firms reported good numbers in their Q1 reporting, comments from Boeing executives regarding their forecast for 2014 spooked the markets and caused the stock to tumble by more than 11% in a ten day period. Fund products offer diversification which gives some investors comfort so a shift was probably inevitable.
Investorideas.com: How do you see the year shaping up going forward?
SMS: Congress and the White House reaching agreement on an FY-14 budget is a great positive as it starts to clarify what the Department of Defense can and will do with the funds allocated to them. A proposed $535 billion core budget would be $36 billion over the sequester-mandated cap with the administration offsetting this increase by reducing other areas in the federal budget. According to Defense News, as part of the budget deal agreement put forth by Sen. Patty Murray and Rep Paul Ryan, the expected budget to be submitted to Congress on March 4 th for 2015 is roughly $496 billion and it includes about $30 billion restored to the Pentagon in 2014 and 2015. We can start to think of these years as the end of the transition period and a stabilization of the current budget puts us possibly near to the bottom of the budget cycle which should stay flat to improving over the next several years and the budget seeing a boost starting in FY16.
Meanwhile, international sales continue to provide a boost to the domestic market and have a meaningful impact on the bottom line of the large firms. Commercial aerospace, which is still in the early innings of a multi-year cycle, is highlighted by Boeing's backlog for new planes stretching to the end of the decade. Newly announced plans to bridge the 777 with a newer plane in 2020 could stretch the commercial aerospace upcycle to the early part of the next decade fueled by global travel growth.
Investorideas.com: And what concerns would keep investors up at night?
SMS: First, with this Congress and White House, there is always political risk and the plans for defense spending mentioned above could easily change. But at least for the moment, the acrimony appears to be calming down a bit. Second, after such a huge run in the stock market during 2013, some companies are near the top of their valuations. So while economic growth is still expected in 2014, which will help justify their valuations, this year is expected to be more of a stock pickers market. Inflows into ETFs are a signal that investors are confident in a sector and want to stay exposed but might be unsure which firms are the clear winners or which firms are at their peak valuations. While shares in the funds being held by investors are up 50% in just the past two to three months, it is still down 75% from its peak. Although we see the sector performing at least in line with the broader market over the rest of the year, if there is an economic hiccup causing investors to pocket gains and pull funds out of the market, stocks overall would see a decline, not just the aerospace and defense sector.
Investorideas.com: Looking at the future of defense technology, which ones and who do you see as benefitting?
SMS: Glad you asked. I will be spending time at the InvestorIdeas.com Security and Defense Conference on March 11th [2014] in New York City and the event is designed to talk about just this.
While wars are obviously to be avoided if at all possible, the post-war environment has historically been a prime period for innovation. Live conflict gives military commanders and planners a chance to evaluate what worked and what didn't work. And from these discussions needs are identified, a plan of action is put in place, and resources are allocated to develop the systems and technologies to eliminate the perceived shortcomings. While new technologies may spring up that provide the military with a previously unforeseen strategic edge, much of the R&D that occurs fits into one of two categories: (1) fixing problems and meeting needs and (2) developing counter technologies.
Additional opportunities can also come from the wave of military personnel entering or returning to the non-military workforce and take the technologies and the lessons learned in warfare and applying them to more, let's say, mundane applications. Post-war medical services and triage capabilities rise as an influx of trained personnel return to society. The application of GPS and positioning technologies for commercial activities expanded after the Gulf War in the 1990s. Although the military bought many of its commercial handheld devices from suppliers such as Radio Shack (true, by the way), GPS becoming a commonplace tool took off following the war as hundreds of thousands of people gained familiarity and exposure to the technology.
Investorideas.com: So what types of technology can we expect to see a boost in the near-term?
SMS: I think they’d fall into three categories.
First, protect the soldier when they are exposed to dangerous situations; and reduce the weight they have to carry through multi-purpose electronics, better reusable power sources, and new water technologies.
Second, the digital warfighter, namely improving the interoperability of different systems they have to use and not overwhelming the soldier with information; and
Third, cyber which is an ongoing battle that is currently being fought on multiple fronts. Investors should obviously keep their eyes open for opportunities in each of these areas.
Investors should obviously keep their eyes open for opportunities in each of these areas.
Investorideas.com: You also mentioned counter technologies.
SMS: Yes, thanks for bringing that back up. If we look back at the history of warfare, it's always been a concept of gaining an edge over ones enemies or adversaries. Whether better bows and arrow, catapults or more modern examples. The implementation of the tank in World War I was designed to disrupt trench warfare. Advances in guns and projectiles led to armor shielded vehicles which in turn led to anti-tank weapons. Planes led to anti-aircraft and radar technologies which in turn spawned the need for missiles which were faster and harder to shoot down. Satellite sensors and missile warning systems were then developed to prevent enemies from shooting down spy planes and identify the launch of missiles and rockets to provide more time to mount a proper defense. GPS enabled more precision targeting of expensive ordnance so technologies to jam and disrupt the signals were developed. IEDs were used to disrupt U.S. forces in Iraq so technologies were developed to counter whether V-shaped undercarriages of vehicles to divert the force from the explosion to improved armor and plating for vehicles. It's a cycle. Roughly every twenty years for more than a century, new technologies and systems are developed that change the way warfare is conducted. And these revolutions led to the development of counter technologies and counters to the counter. It essentially exists for every system and technology in play.
Investorideas.com: Thank you. Something for our readers to think about.
Scott Sacknoff manages the SPADE Defense Index which serves as the underlying index for InvescoPowershares Aerospace & Defense ETF (NYSE ticker: PPA).
Learn more about the conference:
http://www.investorideas.com/Conference
Presenting Companies
See the growing list of companies: http://www.investorideas.com/Conference/Companies.asp

Investorideas.com Security and Defense Conference:
Game Changing Technologies: The Face and Future of Security
Tuesday, March 11, 2014
The New York Hilton Midtown and Online at a unique content and syndication platform

Investors, media and industry service providers: Register here free: http://www.investorideas.com/Conference/Conference-Registration.asp
Presenting Companies: Visit the conference page to learn more and sign up:
http://www.investorideas.com/Conference
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
Presenting Companies Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
Sponsorship info:
Eric Salvarezza esalvarezza@investorideas.com 631. 664. 1311
Media Partners:
Dawn V dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

InvestorIdeas.com Newswire